Publicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (20)

2024

  1. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

    Viruses, Vol. 16, Núm. 3

2023

  1. Atherogenic dyslipidaemia in type 2 diabetes mellitus: The PREDISAT study

    Lipids, Vol. 58, Núm. 4, pp. 197-206

2022

  1. Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19

    PloS one, Vol. 17, Núm. 1, pp. e0261711

  2. Use of glucocorticoids megadoses in SARSCoV- 2 infection in a spanish registry: SEMICOVID- 19

    PLoS ONE, Vol. 17, Núm. 1 January

2021

  1. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  2. Gender-based differences by age range in patients hospitalized with covid-19: A spanish observational cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-21

  3. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

    BMC Infectious Diseases, Vol. 21, Núm. 1

  4. Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model

    Clinical Microbiology and Infection, Vol. 27, Núm. 12, pp. 1838-1844

2019

  1. Non-HDL cholesterol as a therapeutic goal

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 28-33

  2. Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects

    Clinica e Investigacion en Arteriosclerosis

2018

  1. Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 4, pp. 188-192

2017

  1. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease

    Clinica e Investigacion en Arteriosclerosis

  2. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease

    Clinica e Investigacion en Arteriosclerosis

2016

  1. El papel de la dislipemia aterogénica en las guías de práctica clínica

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, Núm. 2, pp. 65-70

2014

  1. Consenso de expertos sobre propuestas para la mejora del manejo de la dislipemia aterogénica

    Revista Espanola de Cardiologia, Vol. 67, Núm. 1, pp. 36-44

  2. Decálogo de recomendaciones clínicas en dislipidemia aterogénica

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 1, pp. 38-40

2012

  1. Perfil lipídico residual en la cardiopatía isquémica recurrente

    Medicina Clinica, Vol. 138, Núm. 6, pp. 238-241

2011

  1. Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 64, Núm. 7, pp. 579-586

2010

  1. A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes

    Clinical Cardiology, Vol. 33, Núm. 7, pp. 418-423

  2. Cocientes lipoproteicos: significado fisiológico y utilidad clínica de los índices aterogénicos en prevención cardiovascular

    Clinica e Investigacion en Arteriosclerosis, Vol. 22, Núm. 1, pp. 25-32